Resveratrol affects the expression of uric acid transporter by improving inflammation

Zhang,Xuemei; Nie,Qian; Zhang,Zhimei; Zhao,Jing; Zhang,Fengxiao; Wang,Chao; Wang,Xing; Song,Guangyao

doi:10.3892/mmr.2021.12203

Resveratrol affects the expression of uric acid transporter by improving inflammation

Authors:
- Xuemei Zhang
- Qian Nie
- Zhimei Zhang
- Jing Zhao
- Fengxiao Zhang
- Chao Wang
- Xing Wang
- Guangyao Song
View Affiliations

Affiliations: Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050000, P.R. China, Department of Rheumatism and Immunology, Hebei General Hospital, Shijiazhuang, Hebei 050000, P.R. China, Hebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang, Hebei 050000, P.R. China
Published online on: June 7, 2021 https://doi.org/10.3892/mmr.2021.12203
Article Number: 564
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Resveratrol (RSV), a polyphenol, non‑flavonoid plant‑derived antitoxin, ameliorates hyperuricemia and kidney inflammation. The present study aimed to establish a model of high‑fat diet (HFD)‑induced insulin resistance (IR) and to determine the specific mechanism of RSV to improve kidney inflammation and reduce uric acid (UA). C57BL/6J mice were fed a HFD for 12 weeks and their glucose tolerance was evaluated by intraperitoneal glucose tolerance testing. The mice were then administered RSV for 6 weeks, and blood and kidney samples were collected. Serum UA and insulin concentrations were determined using ELISA kits. Hematoxylin and eosin, periodic acid‑Schiff and Masson staining were performed to observe the pathological changes of the kidney, and electron microscopy was used to observe changes in the kidney ultrastructure. The renal concentrations of interleukin (IL)‑6, IL‑18, IL‑1β and tumor necrosis factor‑α (TNF‑α) were measured using ELISA kits, and western blotting evaluated changes in the protein expression levels of various indicators. RSV significantly ameliorated HFD‑induced IR and reduced blood UA levels. Long‑term IR can lead to lipid deposition, glycogen accumulation, inflammatory damage and fibrotic changes in the kidney of mice. This leads to a significant increase in the expression of UA transport‑related proteins, an increase in UA reabsorption and an increase in blood UA levels. Notably, RSV intervention was able to reverse this process. The effect of RSV may be achieved by inhibiting the NOD‑like receptor family, pyrin domain‑containing 3 (NLRP3) inflammasome and Toll‑like receptor 4 (TLR4)/myeloid differentiation factor 88/nuclear factor‑κB signaling pathway. In conclusion, RSV may improve kidney inflammation through TLR4 and NLRP3 signaling pathways, and reduce the expression of UA transporter proteins in the kidney of insulin‑resistant mice, thereby reducing blood UA levels.

View Figures

View References

1	El Ridi R and Tallima H: Physiological functions and pathogenic potential of uric acid: A review. J Adv Res. 8:487–493. 2017. View Article : Google Scholar : PubMed/NCBI
2	Billiet L, Doaty S, Katz JD and Velasquez MT: Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol. 2014:8529542014. View Article : Google Scholar : PubMed/NCBI
3	Sharaf El Din UAA, Salem MM and Abdulazim DO: Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J Adv Res. 8:537–548. 2017. View Article : Google Scholar : PubMed/NCBI
4	Tan PK, Farrar JE, Gaucher EA and Miner JN: Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout. Mol Biol Evol. 33:2193–2200. 2016. View Article : Google Scholar : PubMed/NCBI
5	Ebert K, Ludwig M, Geillinger KE, Schoberth GC, Essenwanger J, Stolz J, Daniel H and Witt H: Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters. J Membr Biol. 250:171–182. 2017. View Article : Google Scholar : PubMed/NCBI
6	Yang Y, Zhang DM, Liu JH, Hu LS, Xue QC, Ding XQ and Kong LD: Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice. J Ethnopharmacol. 169:49–59. 2015. View Article : Google Scholar : PubMed/NCBI
7	Akira S, Takeda K and Kaisho T: Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol. 2:675–680. 2001. View Article : Google Scholar : PubMed/NCBI
8	Zeng XZ, Zhang YY, Yang Q, Wang S, Zou BH, Tan YH, Zou M, Liu SW and Li XJ: Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca²⁺-NFATc1 signaling pathway. Acta Pharmacol Sin. 41:229–236. 2020. View Article : Google Scholar : PubMed/NCBI
9	Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, Correia JS, Ulevitch RJ, Hoffman HM and McKay DB: An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol. 185:6277–6285. 2010. View Article : Google Scholar : PubMed/NCBI
10	Thiel G and Rössler OG: Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors. Pharmacol Res. 117:166–176. 2017. View Article : Google Scholar : PubMed/NCBI
11	Cheng K, Song Z, Chen Y, Li S, Zhang Y, Zhang H, Zhang L, Wang C and Wang T: Resveratrol protects against renal damage via attenuation of inflammation and oxidative stress in high-fat-diet-induced obese mice. Inflammation. 42:937–945. 2019. View Article : Google Scholar : PubMed/NCBI
12	Saldanha JF, Leal VO, Stenvinkel P, Carraro-Eduardo JC and Mafra D: Resveratrol: Why is it a promising therapy for chronic kidney disease patients? Oxid Med Cell Longev. 2013:9632172013. View Article : Google Scholar : PubMed/NCBI
13	Jørgensen MS, Tornqvist KS and Hvid H: Calculation of glucose dose for intraperitoneal glucose tolerance tests in lean and obese mice. J Am Assoc Lab Anim Sci. 56:95–97. 2017.
14	Bhatt JK, Thomas S and Nanjan MJ: Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 32:537–541. 2012. View Article : Google Scholar : PubMed/NCBI
15	Shu L, Hou G, Zhao H, Huang W, Song G and Ma H: Resveratrol improves high-fat diet-induced insulin resistance in mice by downregulating the lncRNA NONMMUT008655.2. Am J Transl Res. 12:1–18. 2020.PubMed/NCBI
16	Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G and Quon MJ: Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 85:2402–2410. 2000. View Article : Google Scholar : PubMed/NCBI
17	Brenner C, Simmonds RE, Wood S, Rose V, Feldmann M and Turner J: TLR signalling and adapter utilization in primary human in vitro differentiated adipocytes. Scand J Immunol. 76:359–370. 2012. View Article : Google Scholar : PubMed/NCBI
18	O'Neill LA, Dunne A, Edjeback M, Gray P, Jefferies C and Wietek C: Mal and MyD88: Adapter proteins involved in signal transduction by Toll-like receptors. J Endotoxin Res. 9:55–59. 2003. View Article : Google Scholar
19	Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ and Mansell A: MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem. 284:24192–24203. 2009. View Article : Google Scholar : PubMed/NCBI
20	Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 127:1109–1122. 2006. View Article : Google Scholar : PubMed/NCBI
21	Zhao J, Wang H, Dai C, Wang H, Zhang H, Huang Y, Wang S, Gaskin F, Yang N and Fu SM: P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway. Arthritis Rheum. 65:3176–3185. 2013. View Article : Google Scholar : PubMed/NCBI
22	Zhou R, Yazdi AS, Menu P and Tschopp J: A role for mitochondria in NLRP3 inflammasome activation. Nature. 469:221–225. 2011. View Article : Google Scholar : PubMed/NCBI
23	Roger T, David J, Glauser MP and Calandra T: MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature. 414:920–924. 2001. View Article : Google Scholar : PubMed/NCBI
24	Albert D, Scudder PN, Bagley P and Saag KG: Vascular consequences of hyperuricemia and hypouricemia. Rheum Dis Clin North Am. 45:453–464. 2019. View Article : Google Scholar : PubMed/NCBI
25	Kostka-Jeziorny K, Widecka K and Tykarski A: Study of epidemiological aspects of hyperuricemia in Poland. Cardiol J. 26:241–252. 2019. View Article : Google Scholar : PubMed/NCBI
26	Zhang S, Wang Y, Cheng J, Huangfu N, Zhao R, Xu Z, Zhang F, Zheng W and Zhang D: Hyperuricemia and Cardiovascular Disease. Curr Pharm Des. 25:700–709. 2019. View Article : Google Scholar : PubMed/NCBI
27	Doualla M, Halle MP, Moutchia J, Tegang S and Ashuntantang G: Determinants of hyperuricemia in non-dialysed chronic kidney disease patients in three hospitals in Cameroon. BMC Nephrol. 19:1692018. View Article : Google Scholar : PubMed/NCBI
28	Yang H, Bai W, Gao L, Jiang J, Tang Y, Niu Y, Lin H and Li L: Mangiferin alleviates hypertension induced by hyperuricemia via increasing nitric oxide releases. J Pharmacol Sc. 137:154–161. 2018. View Article : Google Scholar : PubMed/NCBI
29	Sha J, Sui B, Su X, Meng Q and Zhang C: Alteration of oxidative stress and inflammatory cytokines induces apoptosis in diabetic nephropathy. Mol Med Rep. 16:7715–7723. 2017. View Article : Google Scholar : PubMed/NCBI
30	Mount PF and Juncos LA: Obesity-Related CKD: When kidneys get the munchies. J Am Soc Nephrol. 28:3429–3432. 2017. View Article : Google Scholar : PubMed/NCBI
31	Wang MX, Zhao XJ, Chen TY, Liu YL, Jiao RQ, Zhang JH, Ma CH, Liu JH, Pan Y and Kong LD: Nuciferine alleviates renal injury by inhibiting inflammatory responses in fructose-fed rats. J Agric Food Chem. 64:7899–7910. 2016. View Article : Google Scholar : PubMed/NCBI
32	Hu QH, Wang C, Li JM, Zhang DM and Kong LD: Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: Renal organic ion transporter involvement. Am J Physiol Renal Physiol. 297:F1080–F1091. 2009. View Article : Google Scholar : PubMed/NCBI